The chemical class known as PATL2 Activators encompasses a diverse group of compounds that are recognized for their ability to influence the activity of PATL2, a protein linked with post-transcriptional gene regulation, including mRNA decay and translational repression. These activators engage in a variety of mechanisms to modulate the cellular pathways that PATL2 is part of, rather than binding directly to the protein itself. By targeting the broader signaling pathways and cellular processes that govern the functional dynamics of PATL2, these activators can modulate the protein's activity. Such modulation can impact the formation of stress granules, the assembly of P-bodies, and the processes of mRNA surveillance and decay, which are critical for maintaining cellular homeostasis and responding to environmental stressors.
Activators in this class can act by altering intracellular levels of second messengers, such as cAMP, which in turn can affect various signaling cascades that indirectly govern the functional state of PATL2. They can also influence the protein's activity by affecting the synthesis, stability, and decay of mRNAs that PATL2 interacts with. For instance, by modulating proteasome activity, some compounds can shift cellular stress responses, possibly affecting the role of PATL2 in the formation of stress granules and P-bodies. Others can interact with the DNA and RNA synthesis machinery, altering the transcriptional landscape in a way that indirectly influences PATL2's involvement in mRNA processing. The activity of this class of compounds underscores the complexities of cellular regulation, where altering one component of a pathway can lead to cascading effects that ripple through related processes. This highlights the intricate interplay between various cellular components and the sophisticated level of control that cells exert over protein functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
A PDE4 inhibitor that increases cAMP levels, which could activate PATL2 by modulating signaling pathways linked to mRNA decay. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions are crucial for many cellular processes, including mRNA metabolism, which could activate PATL2. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $108.00 $780.00 | 3 | |
Induces oxidative stress and could activate PATL2 by affecting stress granule formation in stress responses. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that could activate PATL2 by leading to increased cellular stress and affecting mRNA surveillance. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibits nuclear export, which could activate PATL2 by leading to changes in mRNA metabolism processes. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and inhibits RNA synthesis, which could activate PATL2 by affecting the pool of mRNA substrates. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis and could activate PATL2 by affecting mRNA turnover due to changes in translation dynamics. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that could activate PATL2 by impacting mRNA translation and stability. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that could activate PATL2 by causing changes in gene expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Affects glycogen synthase kinase-3 (GSK-3) activity, which could activate PATL2 by impacting cellular signaling pathways. | ||||||